Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). (Q31055613)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). |
scientific article |
Statements
1 reference
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162). (English)
1 reference
George Wilding
1 reference
Celestia Higano
1 reference
Eric J Small
1 reference
Catherine M Tangen
1 reference
Maha Hussain
1 reference
Paul F Schelhammer
1 reference
James Faulkner
1 reference
E David Crawford
1 reference
Atif Akdas
1 reference
Bryan Donnelly
1 reference
Gary MacVicar
1 reference
Derek Raghavan
1 reference
Southwest Oncology Group Trial 9346 (INT-0162)
1 reference
1 August 2006
1 reference
1 reference
24
1 reference
24
1 reference
3984-3990
1 reference
Identifiers
1 reference
1 reference